Latest news

Discover the BRAVE toolkit, a new approach to assessing COVID-19 vaccine benefits and risks. Using real-world data, it highlights how Vaxzevria’s advantages outweigh rare side effects, guiding informed public health decisions.

We applied a Bayesian mixture model to serological data from Belgium. This revealed nuanced patterns in immunity to varicella-zoster and parvovirus B19.

Our latest preprint dives into a proactive approach to pandemic preparedness, categorizing pathogens based on shared epidemiological traits.

Five years ago, Belgium was on the verge of its first COVID-19 lockdown. This morning on Radio 1, Niel Hens, looked back on what we learned since then.

Newspaper De Standaard reports on most important lessons learned, five year since the start of the pandemic.

Recent data from Infectieradar.be confirm a notable rise in reported respiratory symptoms among participants. Interestingly, the number of doctor visits remains stable.

How do different age groups contribute to COVID-19 spread through unique behaviors and interactions. And what does that mean for the interventions needed?

The recent outbreak of H5N1 bird flu is an emerging public health risk. In our new study, We focus on identifying key epidemiological parameters of the H5N1 and how it might inform our future actions.

The longer someone delays getting vaccinated, the less likely they are to get vaccinated at all. In our new study, we explore how this long-lasting vaccine hesitancy can impact how an epidemic unfolds

Infectieradar has officially launched its fourth year of data collection, inviting citizens across the country to report weekly on their symptoms, or lack thereof, to help us model the spread of infectious diseases like influenza, RSV, and COVID-19.

Last week, we’ve had the pleasure of hosting researchers from across the globe in Hasselt for GEOMED 2024, a conference dedicated to advancing the field of spatial epidemiology.

This year, we once again welcomed 22 participants to Antwerp for the 2024 edition of our 5-day course on mathematical modelling and health economics.

While we know that parvoviral infections are common in children and that the virus continues to infect people at a lower rate into adulthood, there hasn’t been much research on how widespread the infection is overall. Most studies focus specifically on the risks to pregnant women. 

Measles are on the rise again. Countries across the globe are facing new outbreaks and in Belgium, Sciensano is calling on all adults to check their vaccination status and be mindful of the symptoms. What’s driving this new surge in cases?